• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships
ConclusionsWith the evolution of MCS, patient phenotype and outcomes are also changing over time. CF LVAD support is increasingly being used in the less ill patient phenotype and more patients are supported for destination therapy. Mean survival is now approaching 5 years, but adverse events, especially neurologic events, continue to have a detrimental impact on the success of CF LVAD support.
Source: The Annals of Thoracic Surgery - January 26, 2019 Category: Cardiovascular & Thoracic Surgery Source Type: research

SynCardia Temporary Total Artificial Heart as Bridge to Transplantation: Current Results at La Pitie Hospital ORIGINAL ARTICLES: ADULT CARDIAC
Conclusions The SynCardia t-TAH provided acceptable survival to transplantation rates with a remarkably low incidence of neurologic events. Posttransplant survival was similar to that of patients undergoing primary heart transplantation in France.
Source: The Annals of Thoracic Surgery - April 30, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Kirsch, M. E. W., Nguyen, A., Mastroianni, C., Pozzi, M., Leger, P., Nicolescu, M., Varnous, S., Pavie, A., Leprince, P. Tags: Mechanical Circulatory Assistance ORIGINAL ARTICLES: ADULT CARDIAC Source Type: research